Alkermes Ownership | Who Owns Alkermes?


OverviewForecastRevenueFinancialsChartTranscripts

Alkermes Ownership Summary


Alkermes is owned by 105.42% institutional investors, 1.42% insiders. Blackrock is the largest institutional shareholder, holding 17.33% of ALKS shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.04% of its assets in Alkermes shares.

ALKS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAlkermes105.42%1.42%-6.84%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock29.11M17.33%$701.49M
Blackrock funding, inc. /de28.31M17.19%$1.00B
Vanguard group18.01M10.91%$503.85M
Baker bros. advisors lp10.01M6.08%$354.03M
State street9.47M5.75%$334.69M
Renaissance6.16M3.74%$217.83M
American century companies6.07M3.69%$214.71M
Price t rowe associates inc /md/4.66M2.83%$164.94M
Dimensional fund advisors lp4.52M2.75%$159.85M
Commodore capital lp4.20M2.55%$148.51M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Commodore capital lp4.20M8.59%$148.51M
Prosight management, lp513.63K2.98%$18.16M
Soleus capital management1.97M2.82%$69.69M
Bioimpact capital549.26K2.70%$16.48M
Healthinvest partners ab242.47K2.66%$8.24M
Knott david m jr120.00K2.53%$4.24M
Affinity asset advisors1.35M2.47%$47.74M
Bvf inc/il2.00M2.25%$70.72M
Deep track capital, lp3.59M2.07%$126.95M
Baker bros. advisors lp10.01M2.03%$354.03M

Top Buyers

HolderShares% AssetsChange
Holocene advisors, lp2.32M0.20%2.32M
Bvf inc/il2.00M2.25%2.00M
Norges bank1.95M0.01%1.95M
Deep track capital, lp3.59M2.07%1.59M
First trust advisors lp2.97M0.07%1.51M

Top Sellers

HolderShares% AssetsChange
Price t rowe associates inc /md/4.66M0.02%-4.33M
Hardman johnston global advisors---2.67M
Ubs group495.02K0.00%-2.05M
Camber capital management lp---1.50M
Arrowstreet capital, limited partnership---1.45M

New Positions

HolderShares% AssetsChangeValue
Bvf inc/il2.00M2.25%2.00M$70.72M
Norges bank1.95M0.01%1.95M$54.44M
Vanguard fiduciary trust1.13M0.01%1.13M$39.93M
Bain capital life sciences investors610.00K1.95%610.00K$21.57M
Prosight management, lp513.63K2.98%513.63K$18.16M

Sold Out

HolderChange
Financial gravity asset management-1.00
Harbor investment advisory-1.00
Mather group, llc.-2.00
Financial synergies wealth advisors-9.00
Flagship harbor advisors-10.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20263873.48%173,625,031-3.72%1050.88%192-4.48%14314.40%
Dec 31, 2025109-70.05%28,066,494-83.45%170.16%61-68.88%32-75.94%
Sep 30, 2025135-62.60%35,434,318-79.06%210.20%61-69.19%61-48.74%
Jun 30, 2025355-6.58%168,942,978-0.75%1020.94%1943.19%118-10.61%
Mar 31, 20253777.41%169,214,0331.17%1030.99%1856.94%1327.32%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF10.06M6.04%2.13K
Vanguard Total Stock Mkt Idx Inv5.30M3.18%14.14K
Vanguard US Total Market Shares ETF5.16M3.17%-174.71K
Lord Abbett Floating Rate I4.68M2.81%4.68M
Avantis US Small Cap Value ETF3.96M2.37%-
Vanguard Small Cap Index3.84M2.30%-7.80K
iShares Russell 2000 ETF3.82M2.29%32.20K
State Street® SPDR® S&P® Biotech ETF3.40M2.05%-33.65K
Pacer US Small Cap Cash Cows 100 ETF2.98M1.84%-21.71K
T. Rowe Price U.S. Mid-Cap Val Eq Tr-Z2.64M1.62%-69.71K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 01, 2026Hopkinson Craig C. EVP R&D, Chief Medical OfficerSell$375.04K
May 29, 2026Parisi Samuel Joseph VP, Finance (Interim PAO)Sell$687.01K
May 04, 2026Gaffin David Joseph EVP, CLO, Alkermes, Inc.Sell$67.53K
May 01, 2026Hopkinson Craig C. EVP R&D, Chief Medical OfficerSell$300.56K
Apr 06, 2026Gaffin David Joseph EVP, CLO, Alkermes, Inc.Sell$70.32K

Insider Transactions Trends


DateBuySell
2026 Q2-6
2026 Q1-11
2025 Q4-4
2025 Q3--
2025 Q2-2

ALKS Ownership FAQ


Who Owns Alkermes?

Alkermes shareholders are primarily institutional investors at 105.42%, followed by 1.42% insiders and -6.84% retail investors. The average institutional ownership in Alkermes's industry, Biotech Stocks , is 35.75%, which Alkermes exceeds.

Who owns the most shares of Alkermes?

Alkermes’s largest shareholders are Blackrock (29.11M shares, 17.33%), Blackrock funding, inc. /de (28.31M shares, 17.19%), and Vanguard group (18.01M shares, 10.91%). Together, they hold 45.43% of Alkermes’s total shares outstanding.

Does Blackrock own Alkermes?

Yes, BlackRock owns 17.33% of Alkermes, totaling 29.11M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 701.49M$. In the last quarter, BlackRock decreased its holdings by -60.933K shares, a -0.21% change.

Who is Alkermes’s biggest shareholder by percentage of total assets invested?

Commodore capital lp is Alkermes’s biggest shareholder by percentage of total assets invested, with 8.59% of its assets in 4.2M Alkermes shares, valued at 148.51M$.

Who is the top mutual fund holder of Alkermes shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Alkermes shares, with 6.04% of its total shares outstanding invested in 10.06M Alkermes shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools